Powered by: Motilal Oswal
2026-07-10 02:58:44 pm | Source: Accord Fintech
Gujarat Kidney jumps on inking pact to acquire 51% stake in Blue Tree Clinics
Gujarat Kidney jumps on inking pact to acquire 51% stake in Blue Tree Clinics

Gujarat Kidney And Super Speciality is currently trading at Rs. 133.50, up by 2.65 points or 2.03% from its previous closing of Rs. 130.85 on the BSE.

The scrip opened at Rs. 131.25 and has touched a high and low of Rs. 138.00 and Rs. 130.95 respectively. So far 25956 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 148.45 on 25-May-2026 and a 52 week low of Rs. 98.25 on 23-Jan-2026.

Last one week high and low of the scrip stood at Rs. 138.00 and Rs. 126.80 respectively. The current market cap of the company is Rs. 1052.56 crore.

The promoters holding in the company stood at 71.45%, while Institutions and Non-Institutions held 5.44% and 23.10% respectively.

Gujarat Kidney and Super Speciality has entered into a stock purchase agreement with Blue Tree Clinics LLC, Dubai, to acquire 51% stake, through a purchase of equity shares from existing shareholders. Blue Tree Clinics LLC is a polyclinic duly licensed in Dubai, United Arab Emirates and is inter alia engaged in the business of registered activity as Plastic Surgery, Laser Cosmetic, General Dental Clinic and Chiropractic Centre.

The objective is the acquisition for the expansion of existing business of the company into new geographies and with a set of services other than that of provided by the company in India. The cost of acquisition is Rs 19.83 crore, payable in two tranches.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here